Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Hope

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|July 16, 2015
Reductions in immunosuppression after haematological or solid organ cancer diagnosis in kidney transplant recipientsChristopher M Hope, Alice J Krige, Alex Barratt, et al.
Analytical Chemistry|July 11, 2017
Single Cell Level Quantification of Nanoparticle-Cell Interactions Using Mass CytometryAngela Ivask, Andrew J Mitchell, Christopher M Hope, et al.
Kidney International|January 17, 2014
The immune phenotype may relate to cancer development in kidney transplant recipientsChristopher M Hope, Blair S Grace, Katherine R Pilkington, et al.
Human Immunology|August 21, 2016
Angiotensin II type-1 receptor antibody (AT1Rab) associated humoral rejection and the effect of peri operative plasma exchange and candesartanRobert P Carroll, Michael Riceman, Christopher M Hope, et al.
Kidney International|August 13, 2015
Peripheral natural killer cell and allo-stimulated T-cell function in kidney transplant recipients associate with cancer risk and immunosuppression-related complicationsChristopher M Hope, Alexander Troelnikov, William Hanf, et al.
Nephrology (Carlton, Vic.)|March 3, 2015
C4d-negative antibody-mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor-specific antibodiesAlexander Fuss, Christopher M Hope, Susan Deayton, et al.
Stem Cells (Dayton, Ohio)|June 4, 2015
Interleukin-17A-Induced Human Mesenchymal Stem Cells Are Superior Modulators of Immunological FunctionKisha Nandini Sivanathan, Darling M Rojas-Canales, Christopher M Hope, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 28, 2019
Thymus-Derived Regulatory T Cells Exhibit <i>Foxp3</i> Epigenetic Modification and Phenotype Attenuation after Mating in MiceLachlan M Moldenhauer, John E Schjenken, Christopher M Hope, et al.
Mucosal Immunology|January 29, 2020
MicroRNA miR-155 is required for expansion of regulatory T cells to mediate robust pregnancy tolerance in miceJohn E Schjenken, Lachlan M Moldenhauer, Bihong Zhang, et al.
Clinical & Translational Immunology|January 11, 2021
Rapamycin and abundant TCR stimulation are required for the generation of stable human induced regulatory T cellsJuewan Kim, Christopher M Hope, Griffith B Perkins, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Transplant International : Official Journal of the European Society for Organ Transplantation|July 16, 2015
Reductions in immunosuppression after haematological or solid organ cancer diagnosis in kidney transplant recipientsChristopher M Hope, Alice J Krige, Alex Barratt, et al.
Analytical Chemistry|July 11, 2017
Single Cell Level Quantification of Nanoparticle-Cell Interactions Using Mass CytometryAngela Ivask, Andrew J Mitchell, Christopher M Hope, et al.
Kidney International|January 17, 2014
The immune phenotype may relate to cancer development in kidney transplant recipientsChristopher M Hope, Blair S Grace, Katherine R Pilkington, et al.
Human Immunology|August 21, 2016
Angiotensin II type-1 receptor antibody (AT1Rab) associated humoral rejection and the effect of peri operative plasma exchange and candesartanRobert P Carroll, Michael Riceman, Christopher M Hope, et al.
Kidney International|August 13, 2015
Peripheral natural killer cell and allo-stimulated T-cell function in kidney transplant recipients associate with cancer risk and immunosuppression-related complicationsChristopher M Hope, Alexander Troelnikov, William Hanf, et al.
Nephrology (Carlton, Vic.)|March 3, 2015
C4d-negative antibody-mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor-specific antibodiesAlexander Fuss, Christopher M Hope, Susan Deayton, et al.
Stem Cells (Dayton, Ohio)|June 4, 2015
Interleukin-17A-Induced Human Mesenchymal Stem Cells Are Superior Modulators of Immunological FunctionKisha Nandini Sivanathan, Darling M Rojas-Canales, Christopher M Hope, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 28, 2019
Thymus-Derived Regulatory T Cells Exhibit <i>Foxp3</i> Epigenetic Modification and Phenotype Attenuation after Mating in MiceLachlan M Moldenhauer, John E Schjenken, Christopher M Hope, et al.
Mucosal Immunology|January 29, 2020
MicroRNA miR-155 is required for expansion of regulatory T cells to mediate robust pregnancy tolerance in miceJohn E Schjenken, Lachlan M Moldenhauer, Bihong Zhang, et al.
Clinical & Translational Immunology|January 11, 2021
Rapamycin and abundant TCR stimulation are required for the generation of stable human induced regulatory T cellsJuewan Kim, Christopher M Hope, Griffith B Perkins, et al.
Pageof 3